Mitsui Chemicals, Inc.
[Mitsui Chemicals] Announces Acquisition of U.S. Dental Business | June 2026
Mitsui Chemicals will acquire shares and business assets of U.S. Ultradent Corporation for US$900 million, aiming to become a wholly owned subsidiary. The acquisition enhances dental materials business in the U.S. market and accelerates global expansion.
Key Figures
- Acquisition Price: US$900 million
- Ultradent Corporation Sales: US$372.1 million (fiscal year ending December 2025)
- Planned Acquisition Date: September 2026
AI要約
Overview of the Acquisition
Mitsui Chemicals will acquire shares and business assets of Ultradent Corporation for US$900 million on June 12, 2026, with plans to make it a wholly owned subsidiary. Ultradent, based in Utah, USA, is a top global company in whitening and restorative materials. The acquisition aims to strengthen the oral care business in the U.S. market and accelerate global growth. Post-acquisition, Mitsui Chemicals will leverage synergies among its technologies and products along with Kulzer to provide comprehensive dental solutions.
Future Outlook and Impact
The specific impact of this acquisition on Mitsui Chemicals' performance is currently under review, but it is expected to contribute to long-term growth and improved profitability through expansion and synergy creation in the U.S. dental materials sector. The acquisition is scheduled to close in September 2026, and further details on synergies and business development will be announced separately.
Mitsui Chemicals, Inc.
Company overview · Stock price · Financial data · All IR
